A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

ग्रंथसूची विवरण
मुख्य लेखकों:	Chen, Y, Jobanputra, P, Barton, P, Jowett, S, Bryan, S, Clark, W, Fry-Smith, A, Burls, A
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2006

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
द्वारा: Chen, Y, और अन्य
प्रकाशित: (2006)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
द्वारा: Jobanputra, P, और अन्य
प्रकाशित: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
द्वारा: Jobanputra, P, और अन्य
प्रकाशित: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
द्वारा: P. Jobanputra, और अन्य
प्रकाशित: (2002-01-01)

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
द्वारा: K Malottki, और अन्य
प्रकाशित: (2011-03-01)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
द्वारा: Martínez-Pérez Rosalía, और अन्य
प्रकाशित: (2011-11-01)

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
द्वारा: M Rodgers, और अन्य
प्रकाशित: (2011-02-01)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
द्वारा: Clark, W, और अन्य
प्रकाशित: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
द्वारा: Clark, W, और अन्य
प्रकाशित: (2004)

Etanercept for the treatment of rheumatoid arthritis.
द्वारा: Lethaby, A, और अन्य
प्रकाशित: (2013)

Etanercept for the treatment of rheumatoid arthritis.
द्वारा: Blumenauer, B, और अन्य
प्रकाशित: (2003)

Etanercept for the treatment of rheumatoid arthritis
द्वारा: Blumenauer, B, और अन्य
प्रकाशित: (2004)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
द्वारा: Henry Alistair I, और अन्य
प्रकाशित: (2011-11-01)

Infliximab for the treatment of rheumatoid arthritis.
द्वारा: Blumenauer, B, और अन्य
प्रकाशित: (2002)

Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
द्वारा: Stephanie F. Ling, और अन्य
प्रकाशित: (2024-05-01)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
द्वारा: Cummins, C, और अन्य
प्रकाशित: (2002)

Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
द्वारा: Fisher, B, और अन्य
प्रकाशित: (2016)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
द्वारा: Chen HH, और अन्य
प्रकाशित: (2016-02-01)

Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
द्वारा: Areej S. Albahdal, और अन्य
प्रकाशित: (2024-02-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
द्वारा: Barton, P, और अन्य
प्रकाशित: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
द्वारा: Barton, P, और अन्य
प्रकाशित: (2004)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
द्वारा: Clark, W, और अन्य
प्रकाशित: (2003)

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
द्वारा: Clark, W, और अन्य
प्रकाशित: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
द्वारा: Clark, W, और अन्य
प्रकाशित: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
द्वारा: W. Clark, और अन्य
प्रकाशित: (2003-01-01)

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
द्वारा: N Woolacott, और अन्य
प्रकाशित: (2006-09-01)

The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
द्वारा: Jonathan Shepherd, और अन्य
प्रकाशित: (2016-04-01)

Infliximab in the therapy of rheumatoid arthritis
द्वारा: G. V. Lukina, और अन्य
प्रकाशित: (2016-05-01)

Etanercept plus sulfasalazine: added value in rheumatoid arthritis?
द्वारा: Fisher, B, और अन्य
प्रकाशित: (2007)

SB5 shows cross-immunogenicity to adalimumab but not infliximab: results in patients with inflammatory bowel disease or rheumatoid arthritis
द्वारा: Joao Goncalves, और अन्य
प्रकाशित: (2019-12-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
द्वारा: Ruiz Garcia, V, और अन्य
प्रकाशित: (2011)

Infliximab and methotrexate in the treatment of rheumatoid arthritis
द्वारा: Lipsky, P, और अन्य
प्रकाशित: (2000)

Adalimumab in the treatment of early rheumatoid arthritis
द्वारा: Y A Sigidin, और अन्य
प्रकाशित: (2008-04-01)

A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.
द्वारा: Jobanputra, P, और अन्य
प्रकाशित: (2004)

Quality of life of patients with rheumatoid arthritis receiving etanercept
द्वारा: V N Amirdzanova, और अन्य
प्रकाशित: (2009-08-01)

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
द्वारा: E.I. Alexeeva, और अन्य
प्रकाशित: (2009-07-01)

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
द्वारा: E.I. Alexeeva, और अन्य
प्रकाशित: (2009-01-01)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

समान संसाधन

समान संसाधन